Browsing Tag
Cybin Inc.
1 post
Cybin backs FDA’s call to fast-track psychedelic therapeutics as CYB003 advances in Phase 3 trials
Cybin welcomes FDA’s call to fast-track psychedelics for mental health. See how CYB003 is advancing in Phase 3 trials for depression treatment.